SW female mice were immunized and challenged as described in Fig 2. Vaccinated mice were treated with anti-CD4+, anti-CD8+, or isotype control Ab on days -4, -1, 2, 5, and 8 relative to Ft SchuS4 infection and monitored for survival (A). Alternatively, mice were treated with anti-IFN-γ, anti-IL-17A, or isotype control Ab on days -1, 1, 3, and 5 relative to Ft SchuS4 infection and monitored for survival (B). Ft SchuS4 burdens in the lungs and spleens of naïve or vaccinated SW mice treated with depleting Ab specific for IFN-γ or IL-17A (n = 3 mice per group, day 5 post 40 CFU Ft SchuS4 in challenge) (C and D). Panels A & B represents combined results from two independent experiments with a total of 10 mice/ group, panel C is representative of...
<p>Spleen, draining lymph nodes and mesenteric lymph node were removed at 5<sup>th</sup> week after ...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>A. Mice defective in IFN-γ, IL-4 or IL-17A receptor were immunized as described, then challenged ...
SW and C57BL/6 female mice were immunized and challenged as described in Fig 2. Lungs (A & D), BALF ...
SW and C57BL/6 female mice were immunized i.n. with 1x103 CFU of attenuated Ft LVS sodB mutant. Mice...
<p>BALB/c mice were immunized twice (V1 and V2) with 10<sup>7</sup> pfu of D1701-V-HAh5n and depleti...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>1×10<sup>6</sup> bone-marrow-derived BALB/c macrophages were infected with 5 copies of <i>R</i>. ...
<p>(A) The proportions of STCF-specific 1+, 2+ and 3+ cytokine producers (of IFN-γ, TNF-α and IL-2) ...
Wild-type C57BL/6 or I-A-/-I-Enull mice were i.v. injected with 200cfu TAS2010. A) Infection-induced...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>Mice were infected with γHV-68 (black bars, shaded histograms) or MEM only (open bars, open histo...
<p>Levels of IFN-γ ten days, short-term protection (STP), and twelve weeks, long-term protection (LT...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
SW and C57BL/6 male and female mice were primed and boosted i.n. on days 0 and 21 with 1500 ng of iF...
<p>Spleen, draining lymph nodes and mesenteric lymph node were removed at 5<sup>th</sup> week after ...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>A. Mice defective in IFN-γ, IL-4 or IL-17A receptor were immunized as described, then challenged ...
SW and C57BL/6 female mice were immunized and challenged as described in Fig 2. Lungs (A & D), BALF ...
SW and C57BL/6 female mice were immunized i.n. with 1x103 CFU of attenuated Ft LVS sodB mutant. Mice...
<p>BALB/c mice were immunized twice (V1 and V2) with 10<sup>7</sup> pfu of D1701-V-HAh5n and depleti...
<p>Mice were immunized as described in <a href="http://www.plosntds.org/article/info:doi/10.1371/jou...
<p>1×10<sup>6</sup> bone-marrow-derived BALB/c macrophages were infected with 5 copies of <i>R</i>. ...
<p>(A) The proportions of STCF-specific 1+, 2+ and 3+ cytokine producers (of IFN-γ, TNF-α and IL-2) ...
Wild-type C57BL/6 or I-A-/-I-Enull mice were i.v. injected with 200cfu TAS2010. A) Infection-induced...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>Mice were infected with γHV-68 (black bars, shaded histograms) or MEM only (open bars, open histo...
<p>Levels of IFN-γ ten days, short-term protection (STP), and twelve weeks, long-term protection (LT...
<p>(A and B) Protection in vaccinated mice (expressed as Log<sub>10</sub> CFU reduction) compared to...
SW and C57BL/6 male and female mice were primed and boosted i.n. on days 0 and 21 with 1500 ng of iF...
<p>Spleen, draining lymph nodes and mesenteric lymph node were removed at 5<sup>th</sup> week after ...
<p><b>a</b>) WT B6 mice were vaccinated with Ad-YF C,M,E or Ad-YF NS3 and intracranial challenged wi...
<p>A. Mice defective in IFN-γ, IL-4 or IL-17A receptor were immunized as described, then challenged ...